Synthesis and pharmacological properties of novel guanidine derivatives of quinazoline-2,4(1H,3H)-dione

Introduction: Na+/H+ exchanger type 1 (NHE-1) is a validated drug target for the treatment of cardiovascular and ophthalmic diseases due to the cytoprotective, anti-ischemic and anti-inflammatory properties of NHE-1 inhibitors. This article presents data on the synthesis and pharmacological activity...

Full description

Saved in:
Bibliographic Details
Main Authors: Alexander A. Ozerov, Daria V. Merezhkina, Natalia A. Gurova, Lyudmila V. Naumenko, Denis A. Babkov, Victor S. Sirotenko, Roman A. Litvinov, Alena S. Taran, Nadezhda V. Stepanova, Umida M. Ibragimova, Alexander A. Spasov, Vadim A. Kosolapov
Format: Article
Language:English
Published: Belgorod National Research University 2024-09-01
Series:Research Results in Pharmacology
Subjects:
Online Access:https://rrpharmacology.ru/index.php/journal/article/view/486
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841554621001105408
author Alexander A. Ozerov
Daria V. Merezhkina
Natalia A. Gurova
Lyudmila V. Naumenko
Denis A. Babkov
Victor S. Sirotenko
Roman A. Litvinov
Alena S. Taran
Nadezhda V. Stepanova
Umida M. Ibragimova
Alexander A. Spasov
Vadim A. Kosolapov
author_facet Alexander A. Ozerov
Daria V. Merezhkina
Natalia A. Gurova
Lyudmila V. Naumenko
Denis A. Babkov
Victor S. Sirotenko
Roman A. Litvinov
Alena S. Taran
Nadezhda V. Stepanova
Umida M. Ibragimova
Alexander A. Spasov
Vadim A. Kosolapov
author_sort Alexander A. Ozerov
collection DOAJ
description Introduction: Na+/H+ exchanger type 1 (NHE-1) is a validated drug target for the treatment of cardiovascular and ophthalmic diseases due to the cytoprotective, anti-ischemic and anti-inflammatory properties of NHE-1 inhibitors. This article presents data on the synthesis and pharmacological activity studies of novel guanidine derivatives of quinazoline-2,4(1H,3H)-dione 6-11 and reference drugs amiloride, rimeporide, zoniporide, dexamethasone, aminoguanidine, and acetylsalicylic acid. Materials and Methods: Pharmacological properties were assessed using pH-dependent platelets deformation assay, anti-inflammatory activity assay on LPS-stimulated peritoneal macrophages, antiglycation assay, analysis of platelet aggregation in vitro and measurement of intraocular pressure in vivo. Results: Several compounds combine NHE-1 inhibition with antiglaucomic and antiplatelet activity. Compound 11 significantly inhibits pro-inflammatory activation of murine macrophages (IC50 15.64 μM) and effectively suppresses the formation of glycated proteins (38.1±2.6% in C 1 mM). Conclusion: The investigated compounds represent a promising scaffold for development of agents for the treatment of cardiovascular pathologies, glaucoma, excessive inflammation, and late diabetic complications including retina diabetics and thrombosis.
format Article
id doaj-art-3a04ee4298fc43a9a23160b590cbcd08
institution Kabale University
issn 2658-381X
language English
publishDate 2024-09-01
publisher Belgorod National Research University
record_format Article
series Research Results in Pharmacology
spelling doaj-art-3a04ee4298fc43a9a23160b590cbcd082025-01-08T12:36:33ZengBelgorod National Research UniversityResearch Results in Pharmacology2658-381X2024-09-01103738410.18413/rrpharmacology.10.486Synthesis and pharmacological properties of novel guanidine derivatives of quinazoline-2,4(1H,3H)-dioneAlexander A. Ozerov0https://orcid.org/0000-0002-4721-0959Daria V. Merezhkina1https://orcid.org/0000-0002-9848-7149Natalia A. Gurova2https://orcid.org/0000-0002-0670-1444Lyudmila V. Naumenko3https://orcid.org/0000-0002-2119-4233Denis A. Babkov4https://orcid.org/0000-0002-9645-3324Victor S. Sirotenko5https://orcid.org/0000-0003-2249-020XRoman A. Litvinov6https://orcid.org/0000-0002-0162-0653Alena S. Taran7https://orcid.org/0000-0001-8477-254XNadezhda V. Stepanova8https://orcid.org/0000-0002-6629-3729Umida M. Ibragimova9https://orcid.org/0000-0001-9141-4417Alexander A. Spasov10https://orcid.org/0000-0002-7185-4826Vadim A. Kosolapov11https://orcid.org/0000-0002-6702-1207Volgograd State Medical UniversityVolgograd State Medical UniversityVolgograd State Medical UniversityVolgograd State Medical UniversityVolgograd State Medical UniversityVolgograd State Medical UniversityVolgograd State Medical UniversityVolgograd State Medical UniversityVolgograd State Medical UniversityVolgograd State Medical UniversityVolgograd State Medical UniversityVolgograd State Medical UniversityIntroduction: Na+/H+ exchanger type 1 (NHE-1) is a validated drug target for the treatment of cardiovascular and ophthalmic diseases due to the cytoprotective, anti-ischemic and anti-inflammatory properties of NHE-1 inhibitors. This article presents data on the synthesis and pharmacological activity studies of novel guanidine derivatives of quinazoline-2,4(1H,3H)-dione 6-11 and reference drugs amiloride, rimeporide, zoniporide, dexamethasone, aminoguanidine, and acetylsalicylic acid. Materials and Methods: Pharmacological properties were assessed using pH-dependent platelets deformation assay, anti-inflammatory activity assay on LPS-stimulated peritoneal macrophages, antiglycation assay, analysis of platelet aggregation in vitro and measurement of intraocular pressure in vivo. Results: Several compounds combine NHE-1 inhibition with antiglaucomic and antiplatelet activity. Compound 11 significantly inhibits pro-inflammatory activation of murine macrophages (IC50 15.64 μM) and effectively suppresses the formation of glycated proteins (38.1±2.6% in C 1 mM). Conclusion: The investigated compounds represent a promising scaffold for development of agents for the treatment of cardiovascular pathologies, glaucoma, excessive inflammation, and late diabetic complications including retina diabetics and thrombosis.https://rrpharmacology.ru/index.php/journal/article/view/486na /h -exchangernhe-1guanidine derivatives of quinazolineantiglaucomic actionantiglycationantiplatelet activity
spellingShingle Alexander A. Ozerov
Daria V. Merezhkina
Natalia A. Gurova
Lyudmila V. Naumenko
Denis A. Babkov
Victor S. Sirotenko
Roman A. Litvinov
Alena S. Taran
Nadezhda V. Stepanova
Umida M. Ibragimova
Alexander A. Spasov
Vadim A. Kosolapov
Synthesis and pharmacological properties of novel guanidine derivatives of quinazoline-2,4(1H,3H)-dione
Research Results in Pharmacology
na /h -exchanger
nhe-1
guanidine derivatives of quinazoline
antiglaucomic action
antiglycation
antiplatelet activity
title Synthesis and pharmacological properties of novel guanidine derivatives of quinazoline-2,4(1H,3H)-dione
title_full Synthesis and pharmacological properties of novel guanidine derivatives of quinazoline-2,4(1H,3H)-dione
title_fullStr Synthesis and pharmacological properties of novel guanidine derivatives of quinazoline-2,4(1H,3H)-dione
title_full_unstemmed Synthesis and pharmacological properties of novel guanidine derivatives of quinazoline-2,4(1H,3H)-dione
title_short Synthesis and pharmacological properties of novel guanidine derivatives of quinazoline-2,4(1H,3H)-dione
title_sort synthesis and pharmacological properties of novel guanidine derivatives of quinazoline 2 4 1h 3h dione
topic na /h -exchanger
nhe-1
guanidine derivatives of quinazoline
antiglaucomic action
antiglycation
antiplatelet activity
url https://rrpharmacology.ru/index.php/journal/article/view/486
work_keys_str_mv AT alexanderaozerov synthesisandpharmacologicalpropertiesofnovelguanidinederivativesofquinazoline241h3hdione
AT dariavmerezhkina synthesisandpharmacologicalpropertiesofnovelguanidinederivativesofquinazoline241h3hdione
AT nataliaagurova synthesisandpharmacologicalpropertiesofnovelguanidinederivativesofquinazoline241h3hdione
AT lyudmilavnaumenko synthesisandpharmacologicalpropertiesofnovelguanidinederivativesofquinazoline241h3hdione
AT denisababkov synthesisandpharmacologicalpropertiesofnovelguanidinederivativesofquinazoline241h3hdione
AT victorssirotenko synthesisandpharmacologicalpropertiesofnovelguanidinederivativesofquinazoline241h3hdione
AT romanalitvinov synthesisandpharmacologicalpropertiesofnovelguanidinederivativesofquinazoline241h3hdione
AT alenastaran synthesisandpharmacologicalpropertiesofnovelguanidinederivativesofquinazoline241h3hdione
AT nadezhdavstepanova synthesisandpharmacologicalpropertiesofnovelguanidinederivativesofquinazoline241h3hdione
AT umidamibragimova synthesisandpharmacologicalpropertiesofnovelguanidinederivativesofquinazoline241h3hdione
AT alexanderaspasov synthesisandpharmacologicalpropertiesofnovelguanidinederivativesofquinazoline241h3hdione
AT vadimakosolapov synthesisandpharmacologicalpropertiesofnovelguanidinederivativesofquinazoline241h3hdione